| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/06/2023 | 18.1% | Oppenheimer | $39 → $43 | Maintains | Outperform |
| 08/22/2023 | 9.86% | Goldman Sachs | $37 → $40 | Upgrades | Neutral → Buy |
| 07/12/2023 | -1.13% | Morgan Stanley | $27 → $36 | Upgrades | Underweight → Equal-Weight |
| 06/28/2023 | -25.84% | Morgan Stanley | $27 → $27 | Reiterates | Underweight → Underweight |
| 06/21/2023 | -25.84% | Morgan Stanley | → $27 | Reiterates | → Underweight |
| 06/13/2023 | 23.59% | Oppenheimer | $40 → $45 | Maintains | Outperform |
| 04/12/2023 | -25.84% | Morgan Stanley | $28 → $27 | Downgrades | Equal-Weight → Underweight |
| 04/06/2023 | 9.86% | Oppenheimer | $42 → $40 | Maintains | Outperform |
| 03/24/2023 | 15.35% | Oppenheimer | $48 → $42 | Maintains | Outperform |
| 01/11/2023 | 9.86% | Goldman Sachs | → $40 | Downgrades | Buy → Neutral |
| 12/22/2022 | 1.62% | Keefe, Bruyette & Woods | $38 → $37 | Downgrades | Outperform → Market Perform |
| 08/04/2022 | 1.62% | Goldman Sachs | $33 → $37 | Maintains | Buy |
| 07/19/2022 | -23.1% | Morgan Stanley | $32 → $28 | Maintains | Equal-Weight |
| 06/28/2022 | -12.11% | Morgan Stanley | $33 → $32 | Maintains | Equal-Weight |
| 06/07/2022 | 29.09% | Oppenheimer | $50 → $47 | Maintains | Outperform |
| 03/18/2022 | 29.09% | Oppenheimer | $52 → $47 | Maintains | Outperform |
| 03/08/2022 | -3.87% | Morgan Stanley | $40 → $35 | Maintains | Equal-Weight |
| 12/16/2021 | 9.86% | Morgan Stanley | → $40 | Initiates Coverage On | → Equal-Weight |
| 11/16/2021 | 26.34% | Keefe, Bruyette & Woods | → $46 | Downgrades | Outperform → Market Perform |
| 10/01/2021 | 12.61% | Oppenheimer | $40 → $41 | Maintains | Outperform |
| 09/21/2021 | 23.59% | Goldman Sachs | → $45 | Initiates Coverage On | → Buy |
| 09/16/2020 | -42.32% | Keefe, Bruyette & Woods | → $21 | Upgrades | Market Perform → Outperform |
| 06/30/2020 | -28.59% | Oppenheimer | $25 → $26 | Maintains | Outperform |
| 07/11/2019 | -36.83% | Keefe, Bruyette & Woods | → $23 | Assumes | → Market Perform |
What is the target price for Jefferies Financial Gr (JEF)?
The latest price target for Jefferies Financial Gr (NYSE: JEF) was reported by Oppenheimer on September 6, 2023. The analyst firm set a price target for $43.00 expecting JEF to rise to within 12 months (a possible 18.10% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Jefferies Financial Gr (JEF)?
The latest analyst rating for Jefferies Financial Gr (NYSE: JEF) was provided by Oppenheimer, and Jefferies Financial Gr maintained their outperform rating.
When is the next analyst rating going to be posted or updated for Jefferies Financial Gr (JEF)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Jefferies Financial Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Jefferies Financial Gr was filed on September 6, 2023 so you should expect the next rating to be made available sometime around September 6, 2024.
Is the Analyst Rating Jefferies Financial Gr (JEF) correct?
While ratings are subjective and will change, the latest Jefferies Financial Gr (JEF) rating was a maintained with a price target of $39.00 to $43.00. The current price Jefferies Financial Gr (JEF) is trading at is $36.41, which is out of the analyst's predicted range.